Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:leukemia
gptkb:hematologic_cancer |
| gptkbp:affects |
gptkb:mucosa-associated_lymphoid_tissue
gptkb:B_cells lymph nodes spleen |
| gptkbp:commonTreatment |
gptkb:rituximab
gptkb:radiation_therapy chemotherapy |
| gptkbp:firstDescribed |
1994
|
| gptkbp:ICD-10_code |
gptkb:C83.0
|
| gptkbp:isSlowGrowing |
true
|
| gptkbp:medianAge |
60 years
|
| gptkbp:riskFactor |
gptkb:Helicobacter_pylori_infection
gptkb:autoimmune_disease hepatitis C infection |
| gptkbp:subspecies |
gptkb:leukemia
gptkb:extranodal_marginal_zone_lymphoma gptkb:nodal_marginal_zone_lymphoma gptkb:splenic_marginal_zone_lymphoma |
| gptkbp:symptom |
fatigue
weight loss night sweats enlarged lymph nodes |
| gptkbp:transformsInto |
diffuse large B-cell lymphoma
|
| gptkbp:bfsParent |
gptkb:parsaclisib
gptkb:Imbruvica gptkb:ibrutinib |
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
marginal zone lymphoma
|